Cycle Spot on BIOCON (Jun 2025–Jun 2026) — Stokify backtest 2026
In a 2026 Stokify backtest of the Cycle Spot strategy on BIOCON over Jun 2025–Jun 2026, 66.7% of 12 trades closed as winners for a cumulative +38.6% return, averaging +3.2% per trade. These are NSE historical backtest results for research only, not investment advice; past performance does not guarantee future results.
Result
strategy: Cycle Spot · stock: BIOCON · period: Jun 2025–Jun 2026 · 2026-06-24
Backtest statistics (2026)
| win_rate | 66.7% |
|---|---|
| pnl | +38.6% |
| avg_trade | +3.2% |
| entries | 12 |
| wins | 8 |
| losses | 4 |
Limitations
- Backtest on NSE 1-year historical data — not live-traded results; past performance does not guarantee future results.
- This per-stock summary reports win rate, cumulative and average return, and trade counts; it does NOT include a Sharpe ratio or per-stock max drawdown.
- Excludes slippage beyond the engine's fixed assumptions and intraday liquidity gaps.
- Research tool for SEBI-registered professionals — not investment advice.
FAQ
What was the win rate of Cycle Spot on BIOCON over Jun 2025–Jun 2026?
66.7% across 12 trades (8 wins, 4 losses), for a cumulative +38.6% return on NSE historical data. Research only, not advice.
Is this Stokify backtest investment advice?
No. It is historical research on NSE data for SEBI-registered professionals. Past performance does not guarantee future results; final decisions rest with your broker or RA.